Literature DB >> 24318993

Walker 256/B malignant breast cancer cells improve femur angioarchitecture and disrupt hematological parameters in a rat model of tumor osteolysis.

Riadh Badraoui1, Mariem Boubakri, Maissa Bedbabiss, Hmed Ben-Nasr, Tarek Rebai.   

Abstract

This study was designed to assess femur angioarchitecture and hematological effects of Walker 256/B cells in a rat model of tumor osteolysis. Tumor osteolysis was induced by in situ inoculation of Walker 256/B malignant cells. Six other rats were sham operated and served as control. Twenty days later, rats were euthanized, and femurs were collected than radiographed. Angioarchitecture [mean lumen diameter (MLD), wall thickness (WTh), Vessel number, volume, and separation (VNb, VV, and VSp respectively)] was studied by histomorphometry at 2 different positions (P1: diaphysis, and P2: metaphysis) of the operated femora. Some hematological parameters were also assessed. Walker 256/B induced marked tumor osteolysis, with cortical perforation and trabecular destruction, associated increase in bone vascularization (increases of VNb and VV and decrease of VSp). Angioarchitecture of W256/B rats was disorganized and showed large MLD and lower WTh. These effects were more prominent in P2. When compared to Sham group, significantly decreases at levels of red blood cell (RBC), hemoglobin (Hb), hematocrit (Ht), and white blood cell (WBC) were observed in W256/B rats. These results suggest that Walker 256/B cells induced tumor osteolysis, improve hypervasculature especially near the tumoral foci (P2) associated hematological disruption. Besides, tumor vessels showed abnormal (enlarged and thinner) and disorganized morphology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24318993     DOI: 10.1007/s13277-013-1485-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  39 in total

1.  Neuropathic pain features in patients with bone metastases referred for palliative radiotherapy.

Authors:  Marc Kerba; Jackson S Y Wu; Qiuli Duan; Neil A Hagen; Michael I Bennett
Journal:  J Clin Oncol       Date:  2010-10-04       Impact factor: 44.544

Review 2.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

3.  Effect of malignant ascites on antioxidative potency of two tumoral cells-induced bone metastases: Walker 256/B and MatLyLu.

Authors:  R Badraoui; T Rebai
Journal:  Exp Toxicol Pathol       Date:  2010-07-05

Review 4.  Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis.

Authors:  Conor C Lynch
Journal:  Bone       Date:  2010-06-16       Impact factor: 4.398

Review 5.  Imaging bone metastases in breast cancer: evidence on comparative test accuracy.

Authors:  N Houssami; C M Costelloe
Journal:  Ann Oncol       Date:  2011-09-06       Impact factor: 32.976

6.  Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase.

Authors:  Jenna E Fong; Damien Le Nihouannen; Svetlana V Komarova
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

7.  Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.

Authors:  Toru Hiraga; Shinae Kizaka-Kondoh; Kiichi Hirota; Masahiro Hiraoka; Toshiyuki Yoneda
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

8.  Effect of alpha tocopherol acetate in Walker 256/B cells-induced oxidative damage in a rat model of breast cancer skeletal metastases.

Authors:  Riadh Badraoui; Stéphane Blouin; Marie Françoise Moreau; Yves Gallois; Tarek Rebai; Zouhaier Sahnoun; Michel Baslé; Daniel Chappard
Journal:  Chem Biol Interact       Date:  2009-09-23       Impact factor: 5.192

9.  Neovascular niche for human myeloma cells in immunodeficient mouse bone.

Authors:  Hirono Iriuchishima; Keiyo Takubo; Yoshitaka Miyakawa; Ayako Nakamura-Ishizu; Yoshiteru Miyauchi; Nobuyuki Fujita; Kana Miyamoto; Takeshi Miyamoto; Eiji Ikeda; Masahiro Kizaki; Yoshihisa Nojima; Toshio Suda
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

10.  A molecular epidemiology project on diet and cancer: the EPIC-Italy Prospective Study. Design and baseline characteristics of participants.

Authors:  Domenico Palli; Franco Berrino; Paolo Vineis; Rosario Tumino; Salvatore Panico; Giovanna Masala; Calogero Saieva; Simonetta Salvini; Marco Ceroti; Valeria Pala; Sabina Sieri; Graziella Frasca; Maria Concetta Giurdanella; Carlotta Sacerdote; Laura Fiorini; Egidio Celentano; Rocco Galasso; Adriano Decarli; Vittorio Krogh
Journal:  Tumori       Date:  2003 Nov-Dec
View more
  1 in total

1.  HR-LCMS-Based Metabolite Profiling, Antioxidant, and Anticancer Properties of Teucrium polium L. Methanolic Extract: Computational and In Vitro Study.

Authors:  Emira Noumi; Mejdi Snoussi; El Hassane Anouar; Mousa Alreshidi; Vajid N Veettil; Salem Elkahoui; Mohd Adnan; Mitesh Patel; Adel Kadri; Kaïss Aouadi; Vincenzo De Feo; Riadh Badraoui
Journal:  Antioxidants (Basel)       Date:  2020-11-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.